vs

Side-by-side financial comparison of SENSIENT TECHNOLOGIES CORP (SXT) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

SENSIENT TECHNOLOGIES CORP is the larger business by last-quarter revenue ($435.8M vs $220.8M, roughly 2.0× UNIVERSAL TECHNICAL INSTITUTE INC). SENSIENT TECHNOLOGIES CORP runs the higher net margin — 10.1% vs 5.8%, a 4.3% gap on every dollar of revenue. On growth, SENSIENT TECHNOLOGIES CORP posted the faster year-over-year revenue change (54.2% vs 9.6%). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 3.9%).

Sensient Technologies is a global manufacturer and marketer of colors, flavors and fragrances based in Milwaukee, Wisconsin. Their products are used in many foods and beverages, pharmaceuticals, cosmetics, home and personal care products, specialty printing and imaging products, computer imaging and industrial colors. Sensient reported revenue of $1,468 million in 2013. Subdivisions include the Sensient Flavors & Fragrances Group and the Sensient Color Group. Within the Flavors & Fragrances G...

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

SXT vs UTI — Head-to-Head

Bigger by revenue
SXT
SXT
2.0× larger
SXT
$435.8M
$220.8M
UTI
Growing faster (revenue YoY)
SXT
SXT
+44.5% gap
SXT
54.2%
9.6%
UTI
Higher net margin
SXT
SXT
4.3% more per $
SXT
10.1%
5.8%
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
3.9%
SXT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
SXT
SXT
UTI
UTI
Revenue
$435.8M
$220.8M
Net Profit
$44.2M
$12.8M
Gross Margin
Operating Margin
15.3%
7.1%
Net Margin
10.1%
5.8%
Revenue YoY
54.2%
9.6%
Net Profit YoY
28.2%
-42.1%
EPS (diluted)
$1.04
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SXT
SXT
UTI
UTI
Q1 26
$435.8M
Q4 25
$393.4M
$220.8M
Q3 25
$412.1M
$222.4M
Q2 25
$414.2M
$204.3M
Q1 25
$392.3M
$207.4M
Q4 24
$376.4M
$201.4M
Q3 24
$392.6M
$196.4M
Q2 24
$403.5M
$177.5M
Net Profit
SXT
SXT
UTI
UTI
Q1 26
$44.2M
Q4 25
$25.5M
$12.8M
Q3 25
$37.0M
$18.8M
Q2 25
$37.6M
$10.7M
Q1 25
$34.5M
$11.4M
Q4 24
$30.1M
$22.2M
Q3 24
$32.7M
$18.8M
Q2 24
$30.9M
$5.0M
Gross Margin
SXT
SXT
UTI
UTI
Q1 26
Q4 25
31.4%
Q3 25
34.3%
Q2 25
34.5%
Q1 25
33.6%
Q4 24
31.7%
Q3 24
33.2%
Q2 24
32.4%
Operating Margin
SXT
SXT
UTI
UTI
Q1 26
15.3%
Q4 25
9.7%
7.1%
Q3 25
14.0%
11.2%
Q2 25
13.9%
6.9%
Q1 25
13.6%
8.1%
Q4 24
11.2%
13.6%
Q3 24
12.9%
13.3%
Q2 24
12.3%
4.2%
Net Margin
SXT
SXT
UTI
UTI
Q1 26
10.1%
Q4 25
6.5%
5.8%
Q3 25
9.0%
8.4%
Q2 25
9.1%
5.2%
Q1 25
8.8%
5.5%
Q4 24
8.0%
11.0%
Q3 24
8.3%
9.6%
Q2 24
7.7%
2.8%
EPS (diluted)
SXT
SXT
UTI
UTI
Q1 26
$1.04
Q4 25
$0.60
$0.23
Q3 25
$0.87
$0.33
Q2 25
$0.88
$0.19
Q1 25
$0.81
$0.21
Q4 24
$0.71
$0.40
Q3 24
$0.77
$0.35
Q2 24
$0.73
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SXT
SXT
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$38.5M
$162.8M
Total DebtLower is stronger
$767.8M
$101.4M
Stockholders' EquityBook value
$1.2B
$335.9M
Total Assets
$2.3B
$834.0M
Debt / EquityLower = less leverage
0.63×
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SXT
SXT
UTI
UTI
Q1 26
$38.5M
Q4 25
$36.5M
$162.8M
Q3 25
$42.7M
$169.1M
Q2 25
$56.7M
$70.7M
Q1 25
$32.6M
$96.0M
Q4 24
$26.6M
$172.0M
Q3 24
$37.0M
$161.9M
Q2 24
$30.3M
$115.5M
Total Debt
SXT
SXT
UTI
UTI
Q1 26
$767.8M
Q4 25
$709.2M
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$613.5M
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Stockholders' Equity
SXT
SXT
UTI
UTI
Q1 26
$1.2B
Q4 25
$1.2B
$335.9M
Q3 25
$1.2B
$328.1M
Q2 25
$1.2B
$306.8M
Q1 25
$1.1B
$293.9M
Q4 24
$1.1B
$280.0M
Q3 24
$1.1B
$260.2M
Q2 24
$1.1B
$239.4M
Total Assets
SXT
SXT
UTI
UTI
Q1 26
$2.3B
Q4 25
$2.2B
$834.0M
Q3 25
$2.2B
$826.1M
Q2 25
$2.2B
$740.8M
Q1 25
$2.1B
$720.4M
Q4 24
$2.0B
$753.8M
Q3 24
$2.0B
$744.6M
Q2 24
$2.0B
$706.0M
Debt / Equity
SXT
SXT
UTI
UTI
Q1 26
0.63×
Q4 25
0.59×
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.58×
0.43×
Q3 24
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SXT
SXT
UTI
UTI
Operating Cash FlowLast quarter
$3.1M
Free Cash FlowOCF − Capex
$-19.2M
FCF MarginFCF / Revenue
-8.7%
Capex IntensityCapex / Revenue
10.1%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SXT
SXT
UTI
UTI
Q1 26
Q4 25
$44.6M
$3.1M
Q3 25
$44.0M
$57.1M
Q2 25
$48.3M
$18.1M
Q1 25
$-9.0M
$-789.0K
Q4 24
$21.4M
$23.0M
Q3 24
$76.8M
$67.5M
Q2 24
$43.8M
$10.0M
Free Cash Flow
SXT
SXT
UTI
UTI
Q1 26
Q4 25
$12.9M
$-19.2M
Q3 25
$24.2M
$40.6M
Q2 25
$27.1M
$6.8M
Q1 25
$-25.8M
$-11.7M
Q4 24
$-1.7M
$19.6M
Q3 24
$63.6M
$60.0M
Q2 24
$32.0M
$3.0M
FCF Margin
SXT
SXT
UTI
UTI
Q1 26
Q4 25
3.3%
-8.7%
Q3 25
5.9%
18.3%
Q2 25
6.5%
3.4%
Q1 25
-6.6%
-5.7%
Q4 24
-0.5%
9.7%
Q3 24
16.2%
30.6%
Q2 24
7.9%
1.7%
Capex Intensity
SXT
SXT
UTI
UTI
Q1 26
Q4 25
8.0%
10.1%
Q3 25
4.8%
7.4%
Q2 25
5.1%
5.5%
Q1 25
4.3%
5.3%
Q4 24
6.1%
1.7%
Q3 24
3.4%
3.8%
Q2 24
2.9%
4.0%
Cash Conversion
SXT
SXT
UTI
UTI
Q1 26
Q4 25
1.75×
0.24×
Q3 25
1.19×
3.04×
Q2 25
1.28×
1.69×
Q1 25
-0.26×
-0.07×
Q4 24
0.71×
1.04×
Q3 24
2.35×
3.58×
Q2 24
1.42×
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SXT
SXT

Segment breakdown not available.

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons